📊 BTMD Key Takeaways
Is biote Corp. (BTMD) a Good Investment?
Biote Corp demonstrates concerning financial distress with negative stockholders' equity of -$58.5M despite generating positive operating cash flows and profitability. The company's debt burden ($103.1M) significantly exceeds total assets, creating unsustainable leverage that threatens long-term viability even as current operations remain marginally profitable.
biote Corp. shows solid underlying profitability and cash generation, with 18.5% operating margin, 14.1% net margin, and free cash flow of $30.18M on $192.22M of revenue. However, the slight revenue decline, heavy long-term debt load, and negative stockholders' equity materially weaken the balance-sheet profile and limit the quality of the earnings story. Fundamentally, this looks like a profitable but financially constrained business rather than a clear high-quality compounder.
Why Buy biote Corp. Stock? BTMD Key Strengths
- Strong operating margins at 18.5% with net margins of 14.1% indicate profitable core operations
- Positive free cash flow of $30.2M (15.7% FCF margin) demonstrates ability to generate cash from operations
- Healthy ROA of 25.1% shows efficient asset utilization relative to profitability
- Strong profitability relative to revenue, with 18.5% operating margin and 14.1% net margin
- Healthy cash generation, with operating cash flow of $35.19M and free cash flow margin of 15.7%
- High asset efficiency, reflected in ROA of 25.1%
BTMD Stock Risks: biote Corp. Investment Risks
- Negative stockholders' equity of -$58.5M indicates severe balance sheet insolvency and technical bankruptcy
- Long-term debt of $103.1M exceeds total assets of $107.6M, creating dangerous leverage ratios
- Revenue declining 2.5% YoY combined with negative equity suggests deteriorating competitive position unable to support debt load
- Quick ratio of 0.79x indicates potential liquidity strain on short-term obligations
- Revenue declined 2.5% YoY, which raises concern about top-line durability
- Negative stockholders equity indicates a weak capital structure and reduces balance-sheet flexibility
- Long-term debt of $103.12M is high relative to cash of $24.12M and total assets of $107.61M
Key Metrics to Watch
- Stockholders' equity trajectory and debt restructuring efforts
- Operating cash flow sustainability and ability to service long-term debt
- Revenue stabilization and gross margin trends to assess operational health
- Revenue growth trend
- Net debt reduction and stockholders equity improvement
biote Corp. (BTMD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
biote Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
BTMD Profit Margin, ROE & Profitability Analysis
BTMD vs Materials Sector: How biote Corp. Compares
How biote Corp. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is biote Corp. Stock Overvalued? BTMD Valuation Analysis 2026
Based on fundamental analysis, biote Corp. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
biote Corp. Balance Sheet: BTMD Debt, Cash & Liquidity
BTMD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: biote Corp.'s revenue has grown significantly by 20% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.09 reflects profitable operations.
BTMD Revenue Growth, EPS Growth & YoY Performance
BTMD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $48.0M | -$546.0K | $-0.02 |
| Q2 2025 | $48.9M | $3.2M | $0.10 |
| Q1 2025 | $46.8M | -$4.2M | $-0.12 |
| Q3 2024 | $45.6M | -$546.0K | $-0.02 |
| Q2 2024 | $49.2M | -$5.1M | $-0.19 |
| Q1 2024 | $44.8M | -$2.1M | $-0.06 |
| Q3 2023 | $42.0M | $15.0K | $0.00 |
| Q2 2023 | $41.4M | -$2.6M | $-0.25 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
biote Corp. Dividends, Buybacks & Capital Allocation
BTMD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for biote Corp. (CIK: 0001819253)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BTMD
What is the AI rating for BTMD?
biote Corp. (BTMD) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 76% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BTMD's key strengths?
Claude: Strong operating margins at 18.5% with net margins of 14.1% indicate profitable core operations. Positive free cash flow of $30.2M (15.7% FCF margin) demonstrates ability to generate cash from operations. ChatGPT: Strong profitability relative to revenue, with 18.5% operating margin and 14.1% net margin. Healthy cash generation, with operating cash flow of $35.19M and free cash flow margin of 15.7%.
What are the risks of investing in BTMD?
Claude: Negative stockholders' equity of -$58.5M indicates severe balance sheet insolvency and technical bankruptcy. Long-term debt of $103.1M exceeds total assets of $107.6M, creating dangerous leverage ratios. ChatGPT: Revenue declined 2.5% YoY, which raises concern about top-line durability. Negative stockholders equity indicates a weak capital structure and reduces balance-sheet flexibility.
What is BTMD's revenue and growth?
biote Corp. reported revenue of $192.2M.
Does BTMD pay dividends?
biote Corp. pays dividends, with $1.7M distributed to shareholders in the trailing twelve months.
Where can I find BTMD SEC filings?
Official SEC filings for biote Corp. (CIK: 0001819253) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BTMD's EPS?
biote Corp. has a diluted EPS of $0.74.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BTMD a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, biote Corp. has a SELL rating with 76% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BTMD stock overvalued or undervalued?
Valuation metrics for BTMD: ROE of N/A (sector avg: 14%), net margin of 14.1% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy BTMD stock in 2026?
Our dual AI analysis gives biote Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is BTMD's free cash flow?
biote Corp.'s operating cash flow is $35.2M, with capital expenditures of $5.0M. FCF margin is 15.7%.
How does BTMD compare to other Materials stocks?
Vs Materials sector averages: Net margin 14.1% (avg: 10%), ROE N/A (avg: 14%), current ratio 1.22 (avg: 1.6).